Cited 1 time in
Prolonged loss of intercostal muscle mass and its predictors in COVID-19 patients: A retrospective study from tertiary hospital
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Koo, Byeong Ju | - |
| dc.contributor.author | Choi, Ho Cheol | - |
| dc.contributor.author | Choi, Hye Young | - |
| dc.contributor.author | Shin, Hwa Seon | - |
| dc.contributor.author | Won, Jung Ho | - |
| dc.contributor.author | Hong, Seok Jin | - |
| dc.contributor.author | Yang, Won Jeong | - |
| dc.contributor.author | Ahn, Jae Kyeong | - |
| dc.contributor.author | Park, Mi Jung | - |
| dc.date.accessioned | 2024-06-20T08:30:15Z | - |
| dc.date.available | 2024-06-20T08:30:15Z | - |
| dc.date.issued | 2024-05 | - |
| dc.identifier.issn | 0025-7974 | - |
| dc.identifier.issn | 1536-5964 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/70855 | - |
| dc.description.abstract | Sarcopenia is a contributing factor in the development of long-COVID syndrome. We aimed to investigate how intercostal muscle mass changes over 3 months compared to other chest wall muscles following COVID-19 infection, along with identifying factors contributing to intercostal muscle loss during follow-up. We retrospectively studied 110 COVID-19 patients, analyzing muscle masses in the intercostal, pectoralis, and thoracic 12th vertebra level (T12) on initial and follow-up CT scans. Muscle mass was quantitatively assessed using density histogram analysis. We calculated the muscle difference ratio (MDR) as the following formula: (initial muscle mass - follow-up muscle mass)/initial muscle mass. Patients were categorized into 2 groups: <3 months follow-up (n = 53) and >= 3 months follow-up (n = 57). We employed stepwise logistic regression, using intercostal MDR >= 25% in follow-up as an independent variable and age < 65 years, ventilator use, steroid use, follow-up > 3 months, hospital stay > 13 days, body mass index < 18.5 kg/m(2), and female gender as dependent variables. The loss of intercostal muscle was the most severe among the 3 chest wall muscles in the CT follow-up. Intercostal MDR was significantly higher in the >= 3 months follow-up group compared to the < 3 months group (32.5 +/- 23.6% vs 19.0 +/- 21.1%, P = .002). There were no significant differences in pectoralis MDR or T12 MDR between the 2 groups. Stepwise logistic regression identified steroid use (3.494 (1.419-8.604), P = .007) and a follow-up period > 3 months [3.006 (1.339-6.748), P = .008] as predictors of intercostal MDR >= 25%. The intercostal muscle wasting was profound compared to that in the pectoralis and T12 skeletal muscles in a follow-up CT scan, and the intercostal muscle wasting was further aggravated after 3 months of COVID-19 infection. The use of steroids and a follow-up period exceeding 3 months were significant predictors for >= 25% of intercostal muscle wasting in follow-up. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Lippincott Williams & Wilkins Ltd. | - |
| dc.title | Prolonged loss of intercostal muscle mass and its predictors in COVID-19 patients: A retrospective study from tertiary hospital | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1097/MD.0000000000038284 | - |
| dc.identifier.scopusid | 2-s2.0-85195169524 | - |
| dc.identifier.wosid | 001236425500057 | - |
| dc.identifier.bibliographicCitation | Medicine, v.103, no.22, pp E38284 | - |
| dc.citation.title | Medicine | - |
| dc.citation.volume | 103 | - |
| dc.citation.number | 22 | - |
| dc.citation.startPage | E38284 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | General & Internal Medicine | - |
| dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
| dc.subject.keywordPlus | SARCOPENIA | - |
| dc.subject.keywordPlus | SURVIVORS | - |
| dc.subject.keywordPlus | OUTCOMES | - |
| dc.subject.keywordAuthor | COVID-19 | - |
| dc.subject.keywordAuthor | sarcopenia | - |
| dc.subject.keywordAuthor | thoracic wall | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
